Zobrazeno 1 - 10
of 113
pro vyhledávání: '"C M, Ambrus"'
Publikováno v:
Antibioticschemotherapy (Northfield, Ill.). 2(10)
Publikováno v:
Antibioticschemotherapy (Northfield, Ill.). 3(1)
Publikováno v:
Journal of the American Society of Nephrology. 6:1271-1277
Intravenous desferrioxamine (DFO) is the method commonly used to treat aluminum toxicity. This laboratory has developed a hollow fiber device with immobilized DFO, an "Aluminum DFO-HP" (DFO-HP), for the purpose of removing aluminum without the chelat
Publikováno v:
Journal of medicine. 35(1-6)
A patient exposed to agent orange and a gunshot wound during the Vietnam War has developed multiple medical problems including nocardiosis, onychomycosis (Trichophyton rubrum), multiple thromboembolic episodes, hemochromatosis, diabetes mellitus type
Autor:
C M, Ambrus, I, Stadler, C A, Toumbis, A, Stadler, S, Anthone, R, Anthone, P, DeAlarcon, G, Deshpande, J, Conway, A O, Vladutiu, J L, Ambrus
Publikováno v:
Journal of medicine. 30(3-4)
An extracorporeal hollow-fiber device with immobilized desferrioxamine (DFO) was developed for the removal of nontransferrin-bound iron (NTBI) from blood, without the toxicity of parenteral chelation. When blood circulates through the fibers having p
Publikováno v:
Journal of medicine. 30(3-4)
Myocardium reperfusion following coronary artery bypass grafting (CABG) may result in "reperfusion injury" by free radical generations. Since desferrioxamine administration attenuates this syndrome, non-transferrin-bound-iron (NTBI) released into the
Publikováno v:
Research communications in molecular pathology and pharmacology. 110(3-4)
Lead poisoning is a global public health problem. In pregnant women it may result in developmental delays of the fetus, in children it my produce learning disability. Available chelators are nephrotoxic when eliminated as lead-chelator complexes. For
Autor:
C M, Ambrus, J L, Ambrus
Publikováno v:
Journal of medicine. 32(3-4)
Autor:
J L, Ambrus, C M, Ambrus, W, Dembinsky, D, Sykes, M N, Kulaylat, R, Patel, S, Akhter, A, Islam
Publikováno v:
Journal of medicine. 30(5-6)
Thromboembolic disorders are frequent complications in polycythemia vera. In addition to thrombocytosis with hyperaggregability, leukocytosis, and high hematocrit, hyperviscosity syndrome, a new component, is described in the pathophysiology of this
Autor:
C M, Ambrus, J L, Ambrus
Publikováno v:
The New England journal of medicine. 337(3)